In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. sale N.C. State, 22-9, 12-8 in the Atlantic Coast Conference, is finished until the ACC Tournament. cost To be detailed, the average return of stocks after 3 months bought by George M Whitesides is 19.38%. George Thomas Whitesides was CEO of Virgin Galactic, a firm developing commercial space vehicles. [8] He is credited as having played a "pivotal role" in the development of the Corey-House-Posner-Whitesides reaction. Enjoy a 7-Day Free Trial Thru Mar 11, 2023! Interim CFO Brian Piekos Whitesides is active in multiple public service roles. Bushwick Bill Biography; George M Whitesides is the director of Lyra Therapeutics Inc. Whitesides is married to Loretta Hidalgo Whitesides, and they plan to be the first couple to honeymoon in . Looking everywhere and seeing is chemistry in operation.. AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table. sale degree from Harvard University in 1960 and a Ph.D. from the California Institute of Technology (with J.D. of Flowers University Research Professor, Department of Chemistry and Chemical Biology, Walker Prize (Museum of Science, Boston) (2017), Lifetime Achievement Award (Xconomy Awards) (2017), Rieke Award in Organometallic Chemistry (U. Nebraska) (2018). George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $40,280 and over the last 9 years he sold TBPH stock worth over $0. In his legendary career in chemistry, George Whitesides has been a pioneer in microfabrication and nanoscale self-assembly. This space- or spaceflight-related article is a stub. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $41,840 and over the last 9 years he sold TBPH stock worth over $0. Whitesides received the highest Hirsch index rating of all living chemists in 2011. purchase In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . He was part of the Committee on Science, Engineering, and Public Policy, which authored the National Academies' report Rising Above the Gathering Storm (2007). a net As of 11 August 2017 he still owns at least 4,000 units of Theravance Biopharma Inc stock. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Its purpose is to create transformational medicines to improve the lives of patients suffering from serious illnesses. no insider transaction in Lyra Therapeutics Inc (LYRA). George T. Whitesides (George Thomas Whitesides) is the CEO of Virgin Galactic, a company based at the . The oldest executive at Theravance Biopharma Inc is BurtonMalkiel, 87, who is the Independent Director. Other key executives at Lyra Therapeutics Inc include American chemist and professor of chemistryWhitesides is currently 81 years and running. He was a faculty member of the Massachusetts Institute of Technology from 1964 to 1982. Theravance Biopharma Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. , He received an A.B. purchase of 2,488,150 shares made by Edward T Anderson He is the Woodford L. & Ann A. purchase George McClelland Whitesides"" 5 Relationship, Married, Affair. In 2017, he was awarded the Lifetime Achievement award by Xconomy. . He now . and Other key executives at AMAG Pharmaceuticals Inc include Professor George M Whitesides. Shola Shoretire- Wiki, Age, Ethnicity, Girlfriend, Height, Net Worth, Career. Andre's net worth hovers over Less than $1 with a yearly income that's about Under $10K. sale 192 pages. The estimated net worth of George M Whitesides is at least $2 Million dollars as of 2023-03-04. [62], Whitesides and his wife, Barbara, have two sons, George T. and Ben. The estimated Net Worth of George M Whitesides is at least $373 Tisc dollars as of 11 August 2017. Flowers University Professor at Harvard,[14] one of only 24 University Professorships at the institution as of 2014. . (2022) Charge Transport Measured Using the EGaIn Junction through Self-Assembled Monolayers Immersed in Organic Liquids.The Journal of Physical Chemistry. He served for four years on Princeton's Board of Trustees upon graduation. George Whitesides, then CEO of Virgin Galactic, demonstrated sustained leadership in. of 0 shares. Innoviva Inc (INVA)'s detailed insider trading history can be found in Insider Trading Tracker table. CEO of La Jolla Pharmaceutical Larry G. Edwards [10], In 1982, Whitesides moved back to the Department of Chemistry at Harvard University, his alma mater, taking his laboratory with him. . a net Research and Inventions of George M Whitesides have worked in an unusually broad range of areas, including organometallic chemistry, nuclear magnetic resonance (NMR) spectroscopy, applied enzymology, self-assembly, soft lithography, microfluidics, organic surface science, and nanotechnology. 1539-1541. Whitesides has co-founded a nonprofit called Diagnostics for all, which aims to provide healthcare in a world where the cost is very key. FAQ: How old is George Whitesides? degree from Harvard College in 1960 and earned a Ph.D. in chemistry from the California Institute of Technology in 1964, where he worked with John D. Yoonseok. sale George Whitesides is 80, he's been the Independent Director of Theravance Biopharma Inc since 2013. [31], In an article in Nature (2011), Whitesides and John M. Deutch challenged the scientific and chemical communities to become more relevant to current social and environmental issues. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. 20 Neighbors. Andres W Martinez 1 , Scott T Phillips, George M Whitesides, Emanuel Carrilho. His surface chemistry work has examined the process of molecules arranging themselves on a surface. a net 3 Net Worth, Salary, House. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . Ideas worth spreading. sale . There are 18 executives at Theravance Biopharma Inc getting paid more, with RickWinningham having the highest compensation of $5,932,410. The estimated Net Worth of George M Whitesides is at least $382 ezer dollars as of 11 August 2017. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . . George M Whitesides is the director of Innoviva Inc. This work has become a key for developments in nanoscience, electronics, pharmaceutical science, and medical diagnostics. This work has become a basis for developments in nanoscience, electronics, pharmaceutical science and medical diagnostics. of 7,828 shares made by C Ann Merrifield A native of Kentucky, Whitesides earned a bachelors degree from Harvard in 1960 and 1964 with his advisor John D. Roberts (a fellow NMS recipient), a doctorate in chemistry from the California Institute of Technology. Reputation Score: 1.49 - 3.12. Whitesides have co-founded twelve companies with a combined market capitalization. 6. Quotations by George M. Whitesides, American Scientist, Born August 3, 1939. You can select different timeframes to see how George M Whitesides's insider trading performs compared to the benchmark. He stands 6 feet 2 inches (1.88 m) tall, weighs 220 pounds (100 kg). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include The most recent stock trade was executed by Rick E Winningham on 14 December 2022, trading 50,000 units of TBPH stock currently worth $559,500. George M Whitesides. He is also a fellow of the American Association for the Advancement of Science and the American Philosophical Society. [3] He studied in Newton North High School. He was a faculty member of the Massachusetts Institute of Technology from 1964 to 1982. George M. WhitesidesGMW1939-. From 1986 to 2004, Dr. Whitesides was Mallinckrodt Professor of Chemistry at Harvard University. George M. Whitesides. Most of the revenues are generated through the sale of Feraheme and Makena which is a hydroxyprogesterone caproate injection. , Roberts. no insider transaction in Theravance Biopharma Inc (TBPH). Over the past 18 months, The estimated Net Worth of George M Whitesides is at least 374 $ dollars as of 11 August 2017. , He was born on August 3, 1939 and his birthplace is Kentucky, United States. The estimated Net Worth of George M Whitesides is at least $383 Thousand dollars as of 11 August 2017. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. His first appointment was in the chemistry department at MIT. In 1982, Whitesides returned to the Department of Chemistry at Harvard University with his alma mater and took the laboratory with him. from Harvard University. [8] He continued his work with NMR spectroscopy and organometallic compounds, as well as working with polymers. He was a member of the faculty of the Massachusetts Institute of Technology from 1963 to 1982. [53] Also in 2009, George Whitesides was awarded the 2009 Benjamin Franklin Medal in Chemistry by The Franklin Institute in Philadelphia, for his pioneering chemical research in molecular self-assembly and innovative nanofabrication techniques that have resulted in rapid, inexpensive fabrication of ultra small devices. The estimated Net Worth of George M Whitesides is at least $378 Mille dollars as of 11 August 2017. A prolific author and patent holder who has received many awards, he received the highest Hirsch index rating of all living chemists in 2011. and and , a net pulling together NASA Armstrong and local aerospace engineering capacity to address. GuruFocus tracks the stock performance after each of George M Whitesides's buying transactions within different timeframes. Insiders are limited to only officers and/or directors of the company. George M Whitesides is the director of AMAG Pharmaceuticals Inc. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $37,840 and over the last 8 years he sold TBPH stock worth over $0. Erica Paladino. Flowers University Research Professor. Over the past 18 months, His father is George M. Whitesides, a professor of chemistry at Harvard University. Park. , [32] A similar approach is taken by the Whitesides Research Group, of which John A. Rogers has said, "Chemistry was the core expertise that provided the competitive advantage, but there was no sense of chemistry as a narrowly defined discipline. You might contact George M Whitesides via mailing address: C/o Advanced Magnetics Inc, 61 Mooney Street, Cambridge Ma 02138. His work in surface chemistry has examined the 'self-assembly' processes of molecules arranging themselves on a surface. From 1981 to 1997 and between 2000 to 2010, Whitesides ranked 5th on ISIs list of the 1000 most cited chemists and ranked 38th on the list twice. SVP & Chief Financial Officer Aziz Sawaf On average, George trades about 364 units every 0 days since 2014. Whitesides George M Net Worth 2022 and insider trades. Whitesides announced he will be leaving Virgin Galactic to pursue public service, but will still be in an advisory position to the publicly traded company.[7]. Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. . He was a member of the faculty of the Massachusetts Institute of Technology from 1963 to 1982. sale He is also a member of the board of directors of Nano Terra Inc., Arsenal Biomedical, Inc., Lyra Biomedical, Inc., Diagnostics for All, Inc. and Soft Robotics Inc. Dr. Whitesides holds a Ph.D. in Chemistry from the California Institute of Technology and a B.A. Last Updated on June 9, 2019. Flowers University Professor at Harvard University since 2004. a net George M Whitesides made Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Methods for enzyme immobilization and stabilization in extreme environments and altering enzyme properties by chemical modification with site-directed mutagenesis for synthetic purposes are covered. Whitesides was the Chairman of the Reusable Launch Vehicle Working Group of COMSTAC, the advisory committee for the FAA's Commercial Space Transportation Division. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $44,800 and over the last 9 years he sold TBPH stock worth over $0. The largest trade he's ever made was buying 4,000 units of Theravance Biopharma Inc stock on 11 August 2017 worth over $98,760. of 11,026,781 shares. and He is credited as playing a pivotal role in the development of the Corey-House-Posner-Whitesides reaction. Details can be seen in George M Whitesides's Latest Holdings Summary section. Other key executives at Lyra Therapeutics Inc include , . and The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. acquisition Dr. Whitesides was a 1998 recipient of the National Medal of Science. of 0 shares. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $34,480 and over the last 8 years he sold TBPH stock worth over $0. Chief Operating Officer Anthony Casciano [25], Beyond his scientific research, Whitesides is also active in public service. degree from Harvard University in 1960 and a Ph.D. from the California Institute of Technology (with J.D. George M Whitesides is the director of Theravance Biopharma Inc. Bushwick Bill Bio, Age, Height, Wife, Kids, Cancer, Death, Net Worth. , Interim CFO Brian Piekos AMAG Pharmaceuticals Inc primarily uses its nanoparticle technology to develop therapeutic compounds to treat anemia in patients suffering from chronic kidney disease, as well as imaging agents that assist in identifying cancerous tumors. . Theravance Biopharma Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, Stocks and cryptocurrency portfolio tracker. Organometallic chemistry, Nuclear magnetic, Resonance spectroscopy, molecular self-assembly, soft lithography, microfabrication, microfluidics, and nanotechnology are the best work of Whitesides. of 65,000 shares made by Andrew A. Hindman It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. , Product Details. $35.00 30.95 31.95 ISBN 9780674035669. )University of Bath (England, 2015), Memberships and FellowshipsAmerican Academy of Arts and SciencesNational Academy of SciencesNational Academy of EngineeringNational Academy of InventorsAmerican Philosophical SocietyFellow of the American Association for the Advancement of ScienceFellow of the Institute of PhysicsAmerican Physical SocietyNew York Academy of SciencesWorld Technology NetworkAmerican Chemical SocietyForeign Fellow of the Indian National Academy of ScienceHonorary Member of the Materials Research Society of IndiaHonorary Fellow of the Chemical Research Society of IndiaRoyal Netherlands Academy of Arts and SciencesHonorary Fellow of the Royal Society of Chemistry (UK)Institut de France-Acadmie des sciences (2010). George Thomas Whitesides is an American businessman. Scientific Advisory Boards (2010 - present): MC-10, Sun Catalyix, Reliance Corporation (India, 2009-2016); NextGen Jane (2014- ); Breakthrough Energy Ventures (2017 -); Jana Care (2017 -)Boards of Directors (2000 - present; *= current)Genzyme (co-founder), Rohm and Haas, Dexter, Hughes Research Laboratory, Advanced Magnetics, Assemblon, Concurrent Biomedical, Theravance*, Theravance Biopharma*, Surface Logix, Nano-Terra (Founder)*, Arsenal Vascular*, Lyra Therapeutics* Diagnostics for All (501-c-3, Founder)*, MC 10 Corporation, Soft Robotics (Founder)*Editorial BoardsAngewandte Chemie, Langmuir, Small, Lab on a Chip, Soft Robotics.Research InterestsChemistry, materials science, biophysics, the role of water in biomolecular recognition, the hydrophobic effect, complexity and emergence, surface science, microfluidics, paper as a material, self-assembly, micro- and nanotechnology, healthcare for developing economies, catalysis, origin of life, dissipatice systems, soft robotics, rational drug design, simplicity, and infochemistry. George Whitesides, former Virgin Galactic CEO, is running for Congress in California. Innoviva Inc (INVA) George M Whitesides is an American chemist as well as a professor of chemistry at Harvard University. With his wife, Barbara, Whitesides has two sons named Ben, and George T. Whitesides is CEO of Virgin Galactic, a firm developing commercial space vehicles. Share with your friends. Over the past 18 months, Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. [34] Whitesides and Deutch argued that teaching science in ways that address current issues can still lead to foundational work and scientific breakthroughs. Click here to see the complete history of George M Whitesidess form 4 insider trades. [7] He received his A.B. 12 Jun 1992. Gurus may be added or dropped from the GuruFocus site at any time. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. His net worth is expected to be around $2 billion which is studying for a scientist. The performance of stocks bought by George M Whitesides within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. a net . Whitesides have mentored more than 300 graduate students, postdocs, and visiting scholars. Haihui Joy Jiang. Personal Details View All. North Carolina State: The Wolfpack is 41 st in the NET. Its purpose is to create transformational medicines to improve the lives of patients suffering from serious illnesses. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. On average, Theravance Biopharma Inc executives and independent directors trade stock every 67 days with the average trade being worth of $170,082. He is best known for his work in the areas of nuclear magnetic resonance spectroscopy, organometallic chemistry, molecular self-assembly, soft lithography,[3] microfabrication, microfluidics, and nanotechnology.